USFDA NDI notification of Antromax "Antrodia cinnamomea mycelia" BriefingWire.com, 5/23/2021 - The history of Antrodia cinnamomea consumption by indigenous tribes in Taiwan dates back two hundred years ago, while people in the Western world know little about this ingredient. The USFDA NDI acknowledgement without objection to Greenyn's Antromax was the 1st notification after numerous attempts in the past 14 years. We are honored to establish a stepping-stone for the A. cinnamomea to the US health markets estimated at 10 billion US dollars. USFDA acknowledged Antrodia cinnamomea as new dietary ingredients On April 12th, Greenyn Biotechnology Corporation hosted a seminar - "The international development of Taiwan's Antrodia cinnamomea and its clinical application," and announced Antromax's acknowledgement without objection by USFDA NDI. It was a great feat for Greenyn, and will certainly boost the morale of the Antrodia industry to devote more resources in the US market.